Mouse anti-human PIWIL2 mAb
Scientists at the University of Göttingen generated polyklonal and monoclonal antibodies against the new diagnostic tumor marker PIWIL2. The tumor marker PIWIL2 is not present in normal cells (other than testicular), not present in inflammtory tissues but present in almost all cancer cell types. Because of its important role in tumor genesis and therefor early detection of tumors it could be used for first line screening. Monoclonal antibodies against PIWIL2 could be used for tissue analysis in surgery in clinics, detection of PIWIL2 in blood samples (ELISA) and monitoring of reponse to cancer treatment. Furthermore the antibodies could be used for targeting PIWIL2 within a cancer therapy.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Superradiant atoms could push the boundaries of how precisely time can be measured
Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…
Ion thermoelectric conversion devices for near room temperature
The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…
Zap Energy achieves 37-million-degree temperatures in a compact device
New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…
